Immune-mediated inner ear disease

Area of Science:

• Otolaryngology
• Immunology
• Audiology

Background:

• Autoimmune inner ear disease (AIED) is a rare condition, potentially accounting for less than 1% of hearing impairment and dizziness cases.
• Diagnosis is often delayed or missed due to the absence of a definitive diagnostic test.
• AIED is clinically diagnosed based on characteristic symptoms and progression patterns.

Purpose of the Study:

• To describe the clinical presentation and diagnostic challenges of autoimmune inner ear disease.
• To highlight the key features differentiating AIED from other causes of hearing loss.
• To emphasize the importance of recognizing AIED in patients with unexplained sensorineural hearing loss.

Main Methods:

• Clinical case review and analysis of diagnostic criteria for AIED.
• Audiometric and vestibular function assessments in affected individuals.
• Review of co-existing systemic autoimmune conditions.

Main Results:

• AIED presents with rapidly progressive, fluctuating bilateral sensorineural hearing loss (SNHL) over weeks to months.
• Vestibular symptoms (imbalance, vertigo) affect nearly 50% of patients; tinnitus and aural fullness are also common.
• Bilateral hearing loss is typical, though initial unilateral presentation occurs; 15-30% have co-existing systemic autoimmune diseases.

Conclusions:

• AIED is a rare but significant cause of sensorineural hearing loss that requires clinical suspicion for diagnosis.
• The fluctuating, progressive nature of hearing loss and associated vestibular symptoms are key diagnostic indicators.
• Prompt recognition and management are crucial, especially given the potential for co-existing systemic autoimmune conditions.